Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Thyroid Cancer, Anaplastic
Interventions
DRUG

Nexavar

for Unresectable tumors ,After the patient had diagnosed as anaplastic thyroid cancer, Nexavar 400mg Bid was used for neoadjuvant treatment. At 1 month and 2 months after treatment, it was assessed whether surgery could be performed.

PROCEDURE

operation

If computed tomography (CT) evaluates for possible surgical treatment, complete thyroidectomy and cervical lymph node dissection are performed to completely resect thyroid tissue and metastatic lymphatic tissue.

RADIATION

External radiation therapy

As the successful surgery, then continue on the basis of taking on Nexavar plus external beam radiation therapy

Trial Locations (1)

350001

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University

OTHER

NCT03565536 - Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer | Biotech Hunter | Biotech Hunter